Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Toshner

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Canadian Journal of Physiology and Pharmacology|December 18, 2018
Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension <sup>1</sup>Qiuwang Zhang, Liana Zucco, Mark Toshner, et al.
Respiratory Medicine|August 21, 2007
Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Kimberley Goldsmith, Mark Toshner, et al.
Chronic Respiratory Disease|February 21, 2022
The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertensionLucy Robertson, Katherine Bunclark, Robert Mackenzie Ross, et al.
Frontiers in Medicine|August 10, 2019
Arrhythmic Burden and Outcomes in Pulmonary Arterial HypertensionJennifer T Middleton, Angshuman Maulik, Robert Lewis, et al.
Pulmonary Circulation|August 9, 2022
Pulmonary thromboembolic events in COVID-19-A systematic literature reviewPaul M Overton, Mark Toshner, Claire Mulligan, et al.
Life Sciences|March 4, 2014
Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertensionRhoda E Kuc, Myrna Carlebur, Janet J Maguire, et al.
Echo Research and Practice|February 15, 2019
Tricuspid regurgitation and the right ventricle in risk stratification and timing of interventionBushra S Rana, Shaun Robinson, Rajeevan Francis, et al.
The European Respiratory Journal|November 27, 2024
Development of an open-source tool for risk assessment in pulmonary endarterectomyJames Liley, Katherine Bunclark, Michael Newnham, et al.
The European Respiratory Journal|February 25, 2012
Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPHMark Toshner, Jay Suntharalingam, Pierre Fesler, et al.
Pulmonary Circulation|September 29, 2017
Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertensionJules Hernández-Sánchez, Louise Harlow, Colin Church, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Canadian Journal of Physiology and Pharmacology|December 18, 2018
Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension <sup>1</sup>Qiuwang Zhang, Liana Zucco, Mark Toshner, et al.
Respiratory Medicine|August 21, 2007
Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Kimberley Goldsmith, Mark Toshner, et al.
Chronic Respiratory Disease|February 21, 2022
The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertensionLucy Robertson, Katherine Bunclark, Robert Mackenzie Ross, et al.
Frontiers in Medicine|August 10, 2019
Arrhythmic Burden and Outcomes in Pulmonary Arterial HypertensionJennifer T Middleton, Angshuman Maulik, Robert Lewis, et al.
Pulmonary Circulation|August 9, 2022
Pulmonary thromboembolic events in COVID-19-A systematic literature reviewPaul M Overton, Mark Toshner, Claire Mulligan, et al.
Life Sciences|March 4, 2014
Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertensionRhoda E Kuc, Myrna Carlebur, Janet J Maguire, et al.
Echo Research and Practice|February 15, 2019
Tricuspid regurgitation and the right ventricle in risk stratification and timing of interventionBushra S Rana, Shaun Robinson, Rajeevan Francis, et al.
The European Respiratory Journal|November 27, 2024
Development of an open-source tool for risk assessment in pulmonary endarterectomyJames Liley, Katherine Bunclark, Michael Newnham, et al.
The European Respiratory Journal|February 25, 2012
Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPHMark Toshner, Jay Suntharalingam, Pierre Fesler, et al.
Pulmonary Circulation|September 29, 2017
Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertensionJules Hernández-Sánchez, Louise Harlow, Colin Church, et al.
Pageof 10